$6 New Ladies Skull Crossbones Long Sleeve Womens Knitted Boyfriend Women Jumpers, Cardigans Sweatshirts Jumpers Boyfriend,New,Ladies,$6,Long,Knitted,/archprototype227166.html,krutubechannel.com,Sleeve,Womens,Crossbones,Women , Jumpers, Cardigans Sweatshirts , Jumpers,Skull $6 New Ladies Skull Crossbones Long Sleeve Womens Knitted Boyfriend Women Jumpers, Cardigans Sweatshirts Jumpers Boyfriend,New,Ladies,$6,Long,Knitted,/archprototype227166.html,krutubechannel.com,Sleeve,Womens,Crossbones,Women , Jumpers, Cardigans Sweatshirts , Jumpers,Skull New Ladies Skull Crossbones Long Knitted OFFicial store Sleeve Boyfriend Womens New Ladies Skull Crossbones Long Knitted OFFicial store Sleeve Boyfriend Womens

Max 53% OFF New Ladies Skull Crossbones Long Knitted OFFicial store Sleeve Boyfriend Womens

New Ladies Skull Crossbones Long Sleeve Womens Knitted Boyfriend

$6

New Ladies Skull Crossbones Long Sleeve Womens Knitted Boyfriend

|||

New Ladies Skull Crossbones Long Sleeve Womens Knitted Boyfriend

Intro Pullout Text Widget

a leading international journal from BMJ and BSG, publishes cutting-edge gastroenterology and hepatology research

Impact Factor: 23.059
Citescore: 35.6
All metrics >>

Gut is a Plan S compliant Transformative Journal.

Gut is a leading international journal in gastroenterology and hepatology and has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage in all areas of gastroenterology and hepatology. Regular features include articles by leading authorities describing novel mechanisms of disease and new management strategies, both diagnostic and therapeutic, likely to impact on clinical practice within the foreseeable future.

Gut is an official journal of the British Society of Gastroenterology and has two companion titles, Frontline Gastroenterology for education and practice and BMJ Open Gastroenterology for sound science clinical research.

Editor-in-Chief: Professor Emad El-Omar, University of New South Wales, Sydney, Australia
Editorial Board

TOP CITED ARTICLES
Read the most-cited articles from the past three years for free.

SOCIAL MEDIA AND MULTIMEDIA
Keep up-to-date with Gut on Twitter and Facebook, and access videos on our YouTube channel.

The Gut blog is now live - read the latest posts from the team.

Gut publishes podcasts discussing highlights from its issues. Subscribe in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Expandable Language.

COVID-19: a message from BMJ >>

Guidance from BSG: COVID-19 and Endoscopy

Latest Content

COVID-19 Gastroenterology Collection

 

Our new online collection highlights all research relating to the COVID-19 pandemic published by Gut, Frontline Gastroenterology and BMJ Open Gastroenterology. It is updated regularly as new articles are published.

 

All content is free to read and features original research, commentaries, letters and editorials from all three journals published with the British Society of Gastroenterology (BSG)

 

Visit the full BMJ Coronavirus resource collection for all the latest content from across our portfolio

 

Latest Visual Abstract

Visual Abstracts provide summaries of the latest research in a single, visual format

View a high-resolution version of the Visual Abstract and read the full article

Twitter Feed

Altmetrics

Podcasts

Featured Video

Spatial profiling of gastric cancer metastases reveals principles of tumour dissemination

To cite: Sundar R, Liu DH, Hutchins GG, et al. Gut 2021;70:1823-1832.

Read the full article here: link
Objective: Endoscopic mucosal biopsies of primary gastric cancers (GCs) are used to guide diagnosis, biomarker testing and treatment. Spatial intratumoural heterogeneity (ITH) may influence biopsy-derived information. We aimed to study ITH of primary GCs and matched lymph node metastasis.

Conclusions: In GC, regional lymph node metastases are likely to originate from deeper subregions of the primary tumour. Future clinical trials of novel targeted therapies must consider assessment of deeper subregions of the primary tumour and/or metastases as several therapeutically relevant genes are only mutated, overexpressed or amplified in these regions.

Related Content